Petros Pharmaceuticals Price Prediction

Intrinsic Valuation Low Real High 0.00 0.03 13.03 Details

Bollinger Band Projection (param) Lower Middle Band Upper 0.03 0.03 0.04 Details

Petros Pharmaceuticals After-Hype Price Prediction Density Analysis

Petros Pharmaceuticals Estimiated After-Hype Price Volatility

Petros Pharmaceuticals Pink Sheet Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
7.43	13.00	0.15	0.22	22 Events / Month	5 Events / Month	In about 22 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
0.03	0.03	11.86	65,000   Notes

Petros Pharmaceuticals Hype Timeline

Petros Pharmaceuticals is at this time traded for 0.03. The entity has historical hype elasticity of 0.15, and average elasticity to hype of competition of 0.22. Petros is projected to increase in value after the next headline, with the price projected to jump to 0.0341 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is estimated to be 11.86%, whereas the daily expected return is at this time at -7.43%. The volatility of related hype on Petros Pharmaceuticals is about 43333.33%, with the expected price after the next announcement by competition of 0.25. Petros Pharmaceuticals currently holds 7.39 M in liabilities with Debt to Equity (D/E) ratio of 0.31, which is about average as compared to similar companies. Petros Pharmaceuticals has a current ratio of 3.04, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Petros Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Petros Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Petros Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Petros to invest in growth at high rates of return. When we think about Petros Pharmaceuticals' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next projected press release will be in about 22 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Petros Pharmaceuticals Related Hype Analysis

Petros Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Petros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Petros using various technical indicators. When you analyze Petros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Petros Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Petros Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Petros Pharmaceuticals based on analysis of Petros Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Petros Pharmaceuticals depends on current market conditions and Petros Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Petros Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Petros Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Petros Pharmaceuticals' future price predictability will typically decrease when Petros Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Petros Pharmaceuticals often depends not only on the future outlook of the potential Petros Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Petros Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

If you are still planning to invest in Petros Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Petros Pharmaceuticals' history and understand the potential risks before investing.